Zhang Huahua, Ta Qingyin, Feng Yun, Han Jiming
Medical Research and Experimental Center, Yan'an Medical College of Yan'an University, Yan'an 716000, China.
Medical Examination Center, Cardio-Cerebrovascular Disease Hospital, Yan'an University Affiliated Hospital, Yan'an 716000, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2347-2358. doi: 10.12122/j.issn.1673-4254.2024.12.10.
To investigate the role of Holliday cross-recognition protein (HJURP) in tumorigenesis, progression, and immunotherapy responses.
Bioinformatics approaches were used to analyze the expression level of in various cancers and its association with prognosis, clinical stage, and immune cell infiltration using TCGA, GTEx, SangerBox and TIMER 2.0 databases. LinkedOmics database was employed to investigate -related genes and their potential functions in kidney renal clear cell carcinoma (KIRC). The expression of in KIRC samples was examined with immunohistochemistry, Western blotting and qRT-PCR, and the effect of silencing on cell proliferation and migration was tested in cultured KIRC cells.
was highly expressed in 26 cancers with negative correlations with the patients' survival outcomes in 5 cancers including KIRC (<0.05). expression levels was strongly correlated with clinical stages and immune cell infiltration in the tumors. In KIRC, expression was significantly elevated (<0.0001) and showed a positive correlation with TNM stage (<0.05), overall stage (<0.01) and immune cell infiltration. Gene Ontology (GO) functional analysis showed that is predominantly enriched in biological processes such as biological regulation and metabolic processes. Concerning cellular components, is primarily localized to the cell membrane and nucleus. In terms of molecular functions, it is chiefly enriched in activities related to protein binding and ion binding. was highly expressed in both clinical KIRC tissues and KIRC cell lines (<0.001). In cultured KIRC cells, silencing of significantly inhibited cell proliferation and migration abilities.
may serves as an indicator of prognosis and immunotherapy response of KIRC, and its high expression enhances malignant behaviors of KIRC cells.
研究霍利迪交叉识别蛋白(HJURP)在肿瘤发生、发展及免疫治疗反应中的作用。
利用生物信息学方法,通过TCGA、GTEx、SangerBox和TIMER 2.0数据库分析HJURP在各种癌症中的表达水平及其与预后、临床分期和免疫细胞浸润的关系。使用LinkedOmics数据库研究肾透明细胞癌(KIRC)中与HJURP相关的基因及其潜在功能。采用免疫组织化学、蛋白质印迹法和qRT-PCR检测KIRC样本中HJURP的表达,并在培养的KIRC细胞中检测HJURP沉默对细胞增殖和迁移的影响。
HJURP在26种癌症中高表达,在包括KIRC在内的5种癌症中与患者生存结果呈负相关(<0.05)。HJURP表达水平与肿瘤的临床分期和免疫细胞浸润密切相关。在KIRC中,HJURP表达显著升高(<0.0001),与TNM分期(<0.05)、总体分期(<0.01)和免疫细胞浸润呈正相关。基因本体(GO)功能分析表明,HJURP主要富集于生物调节和代谢过程等生物学过程。关于细胞成分,HJURP主要定位于细胞膜和细胞核。在分子功能方面,它主要富集于与蛋白质结合和离子结合相关的活性。HJURP在临床KIRC组织和KIRC细胞系中均高表达(<0.001)。在培养的KIRC细胞中,HJURP沉默显著抑制细胞增殖和迁移能力。
HJURP可能作为KIRC预后和免疫治疗反应的指标,其高表达增强了KIRC细胞的恶性行为。